diaDexus, Inc. – ‘8-K’ for 4/24/02

On:  Monday, 5/13/02   ·   For:  4/24/02   ·   Accession #:  891554-2-3078   ·   File #:  0-26483

in

this entire Filing. an “Entity” Search.

Show

Documents searched

and

each “hit”. the 1st “hit”.

↓↑Hints

Current Report   —   Form 8-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                         4     11K 
 2: EX-99       Exhibit 99.1                                           2     10K 
 3: EX-99       Exhibit 99.2                                           4     18K 

8-K   —   Current Report
Document Table of Contents

8-K
1st Page of 4
TOC
↑Top
Previous
Next
↓Bottom
Just 1st
 
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

 Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): April 24, 2002

VAXGEN, INC.
(Exact name of Registrant as Specified in its Charter)

DELAWARE                   0-26483                94-3236309
(State or other jurisdiction    (Commission File        (I.R.S. Employer        
  of Identification Number)          Number)      incorporation or organization)

 1000 MARINA BLVD., SUITE 200 BRISBANE, CALIFORNIA 94005
 (Address of Principal Administrative Offices)

 Registrants Telephone Number, Including Area Code: (650) 624-1000

8-K
2nd Page of 4
TOC
1st
Previous
Next
↓Bottom
Just 2nd
Item 5. Other Events.                                                           

On April 24, 2002, VaxGen, Inc. (the "Company") announced that the Company's    
AIDS vaccine cleared its seventh safety review with the Data and Safety         
Monitoring Board.                                                               

The press release is filed herewith as Exhibit 99.1 and incorporated herein by  
reference.                                                                      

On May 7, 2002, the Company announced its first quarter results along with the  
resignation of Ruth B. Kunath from the Board of Directors and Audit and         
Compensation Committees. Ms. Kunath did not resign from the Company's Board of  
Directors because of a disagreement with management.                            

The press release is filed herewith as Exhibit 99.2 and incorporated herein by  
reference.                                                                      

Item 7. Financial Statements, Pro Forma Financial Information and Exhibits.     

(c)   Exhibits.                                                                 

EXHIBIT               DESCRIPTION                                     

99.1     Press Release issued April 24, 2002.                         

99.2     Press Release issued May 7, 2002.                            

8-K
3rd Page of 4
TOC
1st
Previous
Next
↓Bottom
Just 3rd
 SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the        
registrant has duly caused this report to be signed on its behalf by the        
undersigned hereunto duly authorized.                                           

                  VaxGen, Inc.
                  (Registrant)

Dated: May 10, 2002                        By:  /s/ Carter A. Lee               
                                       ---------------------------
                         Carter A. Lee
                                 Senior Vice President
                                    Finance & Administration

8-K
Last Page of 4
TOC
1st
Previous
Next
↓Bottom
Just 4th
 EXHIBIT INDEX

EXHIBIT No.  DESCRIPTION                                              
-----------  -----------                                              

99.1      Press Release issued April 24, 2002.                  

99.2      Press Release issued May 7, 2002.                     

Dates Referenced Herein   and   Documents Incorporated by Reference

				Referenced-On Page
This ‘8-K’ Filing		Date		First		Last			Other Filings
Filed on:		5/13/02
		5/10/02		3
		5/7/02		2		4			DEFR14A
For Period End:		4/24/02		1		4
									List all Filings